About this item:

282 Views | 439 Downloads

Author Notes:

Russell R. Kempker, rkempke@emory.edu

This is a response to a letter by Srivastava et al. (https://doi.org/10.1128/AAC.00854-17).

Subjects:

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Microbiology
  • Pharmacology & Pharmacy
  • 1ST-LINE DRUGS
  • TUBERCULOSIS
  • MODEL

Reply to Srivastava et al., “pH Conditions under Which Pyrazinamide Works in Humans”

Tools:

Journal Title:

Antimicrobial Agents and Chemotherapy

Volume:

Volume 61, Number 9

Publisher:

, Pages e01120-17-e01120-17

Type of Work:

Article | Final Publisher PDF

Copyright information:

© 2017 American Society for Microbiology.

Export to EndNote